On 2025-05-13, Moleculin Biotech, Inc. (MBRX) announced earnings per share of $-0.69 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.71.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.41 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-13 | 2025-03-31 | $-0.71 | $-0.69 |
2024-11-08 | 2024-09-30 | $-2.44 | $-2.09 |
2024-08-13 | 2024-06-30 | $-2.10 | $-2.23 |
2024-05-10 | 2024-03-31 | $-3.59 | $-2.02 |
2023-11-13 | 2023-09-30 | $-3.15 | $-2.85 |
2023-08-11 | 2023-06-30 | $-4.20 | $-3.00 |
2023-05-11 | 2023-03-31 | $-3.75 | $-4.20 |
2023-03-22 | 2022-12-31 | $-4.20 | $-3.60 |
2022-11-10 | 2022-09-30 | $-4.05 | $-4.50 |
2022-08-15 | 2022-06-30 | $-3.75 | $-3.60 |
2022-05-11 | 2022-03-31 | $-3.15 | $-3.60 |
2022-03-25 | 2021-12-31 | $-3.15 | $-2.55 |
2021-11-11 | 2021-09-30 | $-3.00 | $-2.25 |
2021-08-12 | 2021-06-30 | $-3.00 | $-2.85 |
2021-05-12 | 2021-03-31 | $-3.90 | $-3.00 |
2020-11-13 | 2020-09-30 | $-8.99 | $-5.40 |
2020-08-12 | 2020-06-30 | $-8.09 | $-7.19 |
2020-05-11 | 2020-03-31 | $-8.99 | $-8.99 |
2020-03-19 | 2019-12-31 | $-10.79 | $-7.19 |
2019-11-12 | 2019-09-30 | $-8.09 | $-8.09 |
2019-08-16 | 2019-06-30 | $-8.09 | $-8.09 |
2019-05-13 | 2019-03-31 | $-8.09 | $-12.59 |
2019-02-21 | 2018-12-31 | $-8.99 | $-8.99 |
2018-11-13 | 2018-09-30 | $-11.69 | $-8.99 |
2018-08-13 | 2018-06-30 | $-12.59 | $-17.99 |
2018-05-15 | 2018-03-31 | $-12.59 | $-9.89 |
2018-03-28 | 2017-12-31 | $-10.79 | $-15.29 |
2017-11-14 | 2017-09-30 | -- | $-12.59 |
2017-08-14 | 2017-06-30 | -- | $-6.30 |
2017-05-15 | 2017-03-31 | -- | $-8.99 |
2017-04-03 | 2016-12-31 | -- | $-10.79 |
2016-11-21 | 2016-09-30 | -- | $-10.79 |
2016-08-15 | 2016-06-30 | -- | $-9.89 |
2016-06-16 | 2016-03-31 | -- | $-4.50 |